# Compliant Innovations

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/compliant-innovations

- Industry: Software
- Headquarters: Sunnyvale, US
- Website: www.docspera.com
- Total disclosed funding: $9.6M
- Latest round: Series B (Sep 12, 2022)
- Investors on record: 4

## About

Compliant Innovations, Inc specializes in surgical scheduling solutions that enhance operational efficiencies in healthcare. Their platform streamlines surgical care management, improving coordination and patient preparedness across various medical specialties.Founded in 2014 and headquartered in Sunnyvale, California, Compliant Innovations, Inc develops innovative solutions for surgical scheduling. The company has undergone strategic pivots, focusing on automation in surgical care management. The founding team includes Brian Bannister, David Findlay, and Sy Fahimi, while Richard Butcher serves as CEO. In September 2022, they raised USD 9.610 mn in Series B funding, co-led by Pier 70 Ventures and Johnson & Johnson Innovation, bringing the total amount raised to USD 9.610 mn with a current company valuation of USD 20.704 mn.DocSpera offers a comprehensive suite of surgical scheduling solutions designed to streamline surgical care management through automation. Their core offerings include Integrated Surgical Scheduling, which enhances coordination across multiple sites and teams, and Patient Readiness and Prioritization, focusing on improving case preparedness while reducing administrative burdens. Additionally, the Automated Vendor Synchronization feature digitizes case planning and effectively manages vendor communications. The company serves over 400 institutions in specialties such as orthopaedics, cardiovascular, dental, and oncology, primarily within the United States and select international markets.DocSpera's revenue model is based primarily on subscription agreements with healthcare providers, allowing continuous access to their software solutions. Clients typically enter annual contracts that may include multiple product offerings such as Integrated Surgical Scheduling and Analytics & Insights, enabling a tailored approach to operational needs. The B2B transactional structure supports healthcare providers in enhancing surgical coordination and patient outcomes. Specific pricing plans are not disclosed, but the value generated through workflow automation and improved case management is evident in the adoption of DocSpera's services by its clientele.Following the recent Series B funding round in September 2022, which raised USD 9.60 mn, Compliant Innovations, Inc plans to utilize these funds to support product development and expand operations. The company aims to launch new products aimed at further automating surgical care management, although specific release dates have not been provided. Additionally, there are plans to expand into new markets, targeting both domestic and international healthcare facilities to broaden their reach and enhance service delivery.

## Funding rounds

- Series B, Sep 12, 2022, $9.6M — Johnson & Johnson Innovation, Pier 70 Ventures
- Series A, Jun 19, 2014 — Attractor Ventures, Lifeforce Ventures, LLC

## Investors

- Attractor Ventures (https://capitalatlas.ai/funds/attractor-ventures) — Series A
- Lifeforce Ventures, LLC — Series A
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series B
- Pier 70 Ventures (https://capitalatlas.ai/funds/pier-70-ventures) — Series B